Copyright
©The Author(s) 2015.
World J Diabetes. Jun 25, 2015; 6(6): 792-806
Published online Jun 25, 2015. doi: 10.4239/wjd.v6.i6.792
Published online Jun 25, 2015. doi: 10.4239/wjd.v6.i6.792
Imaging modality | Anatomy | Metabolism/ function | Spatial resolution | Weakness |
SPECT | Poor | Yes | 0.3-3 mm | Radiation |
PET | Poor | Yes | 1-4 mm | Radiation |
CT | Yes | Yes | 0.5-1 mm | Radiation |
MRI | Yes | Yes | 50-500 μm | Expensive |
Ultrasound | Yes | Yes | Approximately 200 μm | Poor depth penetration |
Optical | Poor | Yes | 0.1-10 mm | Poor depth penetration |
SPECT | PET | ||||
Nuclide | Half-life | γ (KeV%) | Nuclide | Half-life | β+ (KeV%) |
99mTc | 6.02 h | 89 | 18F | 109.8 min | 96.9 |
111In | 2.83 d | 90.2 | 11C | 20.4 min | 99.7 |
123I | 13.2 h | 83 | 13N | 9.98 min | 99.8 |
125I | 60.14 d | 6.5 | 15O | 2.03 min | 99.9 |
124I | 4.18 d | 25.0 | |||
64Cu | 12.7 h | 17.9 | |||
68Ga | 68 min | 90.0 | |||
82Rb | 1.2 min | 99.9 |
SPECT/PET | CT | MR | US | Optical | Application | |
Pancreas (β-cell function) | [18F]-tracer | MRI | Luminescence | Mainly preclinical[61,62] | ||
Pancreas (transplant/ inflammation) | [18F]-tracer | MRI | High-frequency | Preclinical and clinical[63-68] | ||
Kidney | MRI/BOLD-MRI | B-mode/Doppler | Clinical[70-78] | |||
Brain | [123I]- and [99Tc]-tracer | MRI/MRS | Doppler | Clinical[22,82,83] | ||
Vessels/atherosclerosis | [18F]-tracer | Angio-CT | MRI | B-mode | Clinical[85-95,100-106] | |
Ulcerations | [99Tc]-tracer | Hybrid SPECT/CT | MRI | Doppler | HIS | Clinical[113,114,116,117] |
Heart | [18F]-, [123I]- [11C]-tracer | Hybrid PET/CT | MRI/MRS | Doppler | Clinical[95,120-126,130,131,134,135] | |
Visceral fat | CT/dual energy CT | MRI/MRS | B-mode | Clinical[142,145,146] |
- Citation: Barsanti C, Lenzarini F, Kusmic C. Diagnostic and prognostic utility of non-invasive imaging in diabetes management. World J Diabetes 2015; 6(6): 792-806
- URL: https://www.wjgnet.com/1948-9358/full/v6/i6/792.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i6.792